Mangoceuticals, Inc.

NASDAQ (USD): Mangoceuticals, Inc. (MGRX)

Last Price

2.31

Today's Change

-0.13 (5.32%)

Day's Change

2.31 - 2.61

Trading Volume

94,321

Profile
MGRX

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Jacob D. Cohen Mr. Jacob D. Cohen

Full Time Employees:  3 3

IPO Date:  2023-03-21 2023-03-21

CIK:  0001938046 0001938046

ISIN:  US56270V1061 US56270V1061

CUSIP:  56270V106 56270V106

Beta:  0.00 0.00

Last Dividend:  0.00 0.00

Dcf Diff:  0.19 0.19

Dcf:  0.04 0.04

Description

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Address

15110 North Dallas Parkway,
Dallas, TX 75248, US

(214) 242-9619

http://www.mangorx.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment